CCT 137690

• Description:

  A potent, orally bioavailable Aurora kinases inhibitor with IC50 of 15/25/19 nM for Aurora A/B/C; displays antiproliferative activity in a range of human tumor cell lines, including SW620 colon carcinoma (GI50=0.30 uM) and A2780 ovarian cancer cell line (GI50=0.14 uM) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  551.4813

• Molecular Formula:

  C26H31BrN8O

• Notes:

  Research use only, not for human use.

• Receptor:

  AuroraA|AuroraB|AuroraC

• CAS Number:

  1095382-05-0